Clinical Trials: Diabetic Neuropathy

Alabama

Birmingham; University of Alabama at Birmingham, School of Medicine
A Multicenter, Randomized, Double-Blind, Parallel Group Study Comparing the Efficacy and Safety of ARC-4558 (Clonidine Topical Gel 0.1%) with Placebo in the Management of Pain Associated with Painful Diabetic Neuropathy.

Birmingham; Alliance Clinical Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Dothan; HARMONEX
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Haleyville; Winston Technology Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Hoover; Clinical Research Consultants
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Huntsville; Genesis Clinical Research Corporation
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Northport; Neurology Clinic PC
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Tuscaloosa; Neurology Consultants of Tuscaloosa
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Alaska

Little Rock; Clinical Study Centers LLC
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Arizona

Chandler; Radiant Research, Phoenix Southeast
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Peoria; Pivotal Research Centers, LLC
Tingling - Burning - Shooting pain in your feet due to Diabetic Neuropathy? (Peoria, AZ)

Phoenix; Arizona Research Center, Inc
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Tucson; Advanced Clinical Therapeutics
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Tucson; Harmony Clinical, Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Tucson; Genova Clinical Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Tucson; Northwest NeuroSpecialists, PLLC
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Arkansas

Hot Springs; Central Arkansas Research
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Jonesboro; NEA Clinic - Endocrinology
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Little Rock; Clinical Trials, Inc
Painful Diabetic Peripheral Neuropathy

Little Rock; Clinical Trials, Inc.
Painful Diabetic Peripheral Neuropathy

California

Beverly Hills; Lovelace Scientific Resources, Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Carmichael; Northern California Research
A Multicenter, Randomized, Double-Blind, Parallel Group Study Comparing the Efficacy and Safety of ARC-4558 (Clonidine Topical Gel 0.1%) with Placebo in the Management of Pain Associated with Painful Diabetic Neuropathy.

Fresno; Valley Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Garden Grove; Harmony Clinical Research
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Huntington Beach; Diabetes/Lipid Management and Research Center
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Irvine; NervePro Medical Corporation
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

La Jolla; Center for Pain and Palliative Medicine
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

La Jolla; Coordinated Clinical Research (La Jolla, CA)
If you have Type I or Type 2 Diabetes and experience pain, numbness, pins and needles or tingling in your fingers or feet you may qualify to participate in research

La Jolla; Coordinated Clinical Research (La Jolla, CA)
Do you have Diabetes? Are you experiencing pain, tingling, burning, or numbness in your hands or feet?

La Mesa; Diabetes and Endocrine Associates
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

La Mesa; Diabetes and Endocrine Associates
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Los Angeles; Doheny Institute
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Los Angeles; Healthcare Partners Medical Group
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Los Banos; K D Medical Group, Inc
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Rancho Mirage; Southwest Clinical Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

San Francisco; Bay Area Foot Care
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Santa Monica; Neurological Research Institute
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Santa Monica; Neurological Research Institute
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Santa Monica; Coastal Biomedical Research, Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Spring Valley; Encompass Clinical Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Walnut Creek; Diablo Clinical Research
Do you suffer from diabetic neuropathy?

Walnut Creek; Diablo Clinical Research
Diabetic and suffering from symptoms of Neuropathy?

Walnut Creek; Diablo Clinical Research
Do you have Painful Diabetic Neuropathy?

Walnut Creek; Diablo Clinical Research
Attention Diabetics: Pain Relief Study.

Walnut Creek; Diablo Clinical Research
Pain in your feet?

Colorado

Boulder; Alpine Clinical Research Center
Evaluation of a New Medication for Treatment of Painful Diabetic Neuropathy

Boulder; Alpine Clinical Research Centre
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Connecticut

Waterbury; Chase Medical Research, LLC
A Randomized, Double-Blind Placebo Controlled Trial of [S,S]-reboxetine in Patients with Chronic Painful Diabetic Peripheral Neuropathy

Delaware

Wilmington; Community Health Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Florida

Bradenton; Bradenton Neurology, Inc.
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Bradenton; Bradenton Research
Do you suffer from painful diabetic neuropathy?

Clearwater; Clinical Research of West Florida, Inc.
What is Daibetic Peripheral Neuropathy (DPN)?

Clearwater; Clinical Research of West Florida, Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Clearwater; Clinical Research of West Florida, Inc.
Together, we can fight DIABETIC NEUROPATHY PAIN. If your a diabetic who's experiencing tingling or burning foor pain, you can participate in a research study to evaluate an investigational pain medication that is unique in how it effects pain.

Daytona Beach; Covance
Diabetes & Nephropathy?

DeLand; University Clinical Research DeLand, LLC
Phase I Diabetic Neuropathy (31 day inpatient stay)

Deland; University Clinical Research-Deland, LLC
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Delray Beach; Brain Matters Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Fort Myers; Clinical Physiology Associates, Inc.- Clinical Study Center
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Ft. Lauderdale; Neurologic Consultants PA
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Ft. Myers; Clinical Study Center
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Hallandale Beach; MD Clinical
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Hollywood; Sunrise Clinical Research, Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Hollywood; South Florida Clinical Research Center
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Miami; Neuroscience Consultants
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Miami; Gables Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Ormond Beach; Peninsula Research, Inc.
Arthritis Pain needing strong pain medications

Ormond Beach; Peninsula Research, Inc.
High Blood Pressure

Ormond Beach; Peninsula Research, Inc.
Numbness or Pain in feet due to Diabetes/Neuropathy

Palm Beach Gardens; Palm Beach Neurological Center
Neurology

Palm Beach Gardens; Palm Beach Neurological Center
Diabetic Neuropathy

Palm Beach Gardens; Palm Beach Neurological Center
The purpose of this research study is to evaluate the safety and effectiveness of an investigational medication versus placebo (no active medication) to treat Diabetic Peripheral Neuropathy.

Pembroke Pines; University Clinical Research
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

St. Petersburg; Comprehensive NeuroScience, Inc. St. Petersburg
St. Petersburg, FL - Diabetic Neuropathy

St. Petersburg; Comprehensive Neuroscience, Inc.
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Sunrise; Neurology Clinical Research Inc.
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Sunrise; Neurology Clinical Research Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Sunrise; Neurology Clinical Research Inc.
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Tampa; Clinical Research of West Florida, Inc.
Together we can fight DIABETIC NEUROPATHY PAIN.
If you're a diabetic who's experiencing tingling or burning foot pain, you can participate in a research study to evaluate an investigational pain medication that is unique in how it affects pain.

Tampa; Clinical Research of West FL, Inc.
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Tampa; Stedman Clinical Trials
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Tampa; Clinical Research of West Florida
Together We Can Fight Diabetic Neuropathy Pain

Georgia

Dawsonville; North Georgia Premier Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Marietta; Drug Studies America
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Marietta; Drug Studies America
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Illinois

Chicago; Pain and Rehabilitation Clinic of Chicago
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Indiana

Elkhart; Elkhart Clinic, LLC
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Evansville; Medisphere Medical Research Center, LLC
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Evansville; Research Solutions, LLC.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Valparaiso; Northwest Indiana Center for Clinical Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Kentucky

Louisville; L-MARC Research Center
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Madisonville; Commonwealth Biomedical Research LLC
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Louisiana

New Orleans; Tulane University Health Sciences Center
A Multicenter, Randomized, Double-Blind, Parallel Group Study Comparing the Efficacy and Safety of ARC-4558 (Clonidine Topical Gel 0.1%) with Placebo in the Management of Pain Associated with Painful Diabetic Neuropathy.

Maryland

Owings Mills; Crossroads Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Massachusetts

Boston; BWH - Brigham and Women's Hospital
Gene Expression Markers of Pain following Spinal Cord Injury

Brockton; Beacon Clinical Research
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Worcester; University of Massachuetts Medical School, Division of Diabetes- Clinical Research Office
A Multicenter, Randomized, Double-Blind, Parallel Group Study Comparing the Efficacy and Safety of ARC-4558 (Clonidine Topical Gel 0.1%) with Placebo in the Management of Pain Associated with Painful Diabetic Neuropathy.

Michigan

Ann Arbor; Michigan Head-Pain & Neurological Institute
Diabetic Neuropathy Pain

Ann Arbor; Michigan Head Pain & Neurological Institute
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Missouri

St. Louis; Mercy Health Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

St. Louis; Radiant Research, Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Montana

Great Falls; Advanced Neurology Specialists
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Nebraska

Omaha; Creighton Diabetes Center
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Nevada

Las Vegas; University of Wisconsin Hospital and Clinics
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

New Mexico

Albuquerque; Lovelace Scientific Resources, Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

New York

Albany; Upstate Clincal Research, LLC
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Albany; Neurological Associates of Albany
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Albany; Upstate Clinical Research, LLC
If you have diabetes and have numbness, tingling, pain or loss of feeling in your feet, legs, hands or arms, you may be eligible to participate in a research study of an investigational medication.

Buffalo; Kaledia Health / Diabetes-Endocrinology Center of Western New York
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Buffalo; Diabetes-Endocrinology Center of Western New York
Do you have diabetes, and prickling, tingling, numbness, or pain in your hands and feet?

Flushing ; Diabetes Care and Information Center of NY
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

New York; Columbia University Medical Center
Vascular Endothelial Growth Factor for Treatment of Diabetic Neuropathy

New York; Biomedical Research Alliance of New York
Pain relief in patients with peripheral neuropathic pain conditions

Rochester; Rochester Clinical Research
Diabetes - Diabetic Neuropathy

Valley Stream; North American Partners in Pain Management
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Williamsville; Upstate Clinical Research Associates
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

North Carolina

Greenville; ECU Diabetes Research Center
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Winston-Salem; The Center for Clinical Research
A Multicenter, Randomized, Double-Blind, Parallel Group Study Comparing the Efficacy and Safety of ARC-4558 (Clonidine Topical Gel 0.1%) with Placebo in the Management of Pain Associated with Painful Diabetic Neuropathy.

Ohio

Cincinnati; Radiant Research, Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Cincinnati; Hightop Medical Research Center
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Cincinnati; Radiant Research - Cincinnati
Diabetic Neuropathy Research Study

Kettering; Wells Institute for Health Awareness
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Kettering; Wells Institute for Health Awareness
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Mogadore; Radiant Research - Akron
Diabetic Neuropathy Clinical Research

Mogadore; Radiant Research
Do You Feel Numbness, Tingling, Burning, and Pain in Your Feet From Diabetes?

Toledo; Neurology & Neuroscience Center of Ohio
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful Diabetic neuropathy for 6 months to 10 years.

Oklahoma

Oklahoma City; Health Research Institute
Diabetic Peripheral Neuropathy (DPN)

Tulsa; AHS Oklahoma Physicians Group
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Tulsa; Neurological Center of Oklahoma, PLC
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Oregon

Medford; Medford Medical Clinic
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Pennsylvania

Altoona; Allegheny Pain Management
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Downingtown; Brandywine Clinical Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Duncansville; Altoona Center for Clinical Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Morrisville; Bucks County Clinical Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Rhode Island

Warwick; Omega Medical Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

South Carolina

Anderson; Hartwell Research
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Greer; Radiant Research - Greer
Diabetic Neuropathy Research Study.

Greer; Radiant Research, Greer
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Mount Pleasant; Coastal Carolina Research Center
Are you diabetic? Volunteers needed for diabetic peripheral neuropathy or DPN study.

Murrells Inlet; Waccamaw Pain Partners/Crescent Moon Research
A Multicenter, Randomized, Double-Blind, Parallel Group Study Comparing the Efficacy and Safety of ARC-4558 (Clonidine Topical Gel 0.1%) with Placebo in the Management of Pain Associated with Painful Diabetic Neuropathy.

Tennessee

Bristol; Tricities Medical Research
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Nashville; Dial Research Associates, Inc.
Together we can fight diabetic neuropathy pain.

Tullahoma; Progress Clinical Trials
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Texas

Carrollton; MedicalEdge Healthcare Group, PA
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Dallas; Radiant Research - Dallas, North
Diabetic Neuropathy Research Study

Dallas; Radiant Research - Dallas North
Diabetic Neuropathy Research Study

Dallas; Radiant Research Dallas-North
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Houston; Todd J. Swick, M.D., P.A.
Do you suffer from diabetic peripheral neuropathy or post-herpetic neuralgia?

Houston; Nerve and Muscle Center of Texas
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Lake Jackson; R/D Clinical Research, Inc.
Diabetic Pain Research Study

Lake Jackson; R/D Clinical Research, Inc.
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

San Antonio; Diabetes and Glandular Disease Center
A Multicenter, Randomized, Double-Blind, Parallel Group Study Comparing the Efficacy and Safety of ARC-4558 (Clonidine Topical Gel 0.1%) with Placebo in the Management of Pain Associated with Painful Diabetic Neuropathy.

San Antonio; Diabetes & Glandular Disease Research Associates Inc.
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

San Antonio; InVisions Consultants, LLC
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

San Antonio; Clinical Trials of Texas, Inc
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Virginia

Norfolk; Strelitz Diabetes Institute, Eastern Virginia Medical School
A Multicenter, Randomized, Double-Blind, Parallel Group Study Comparing the Efficacy and Safety of ARC-4558 (Clonidine Topical Gel 0.1%) with Placebo in the Management of Pain Associated with Painful Diabetic Neuropathy.

Norfolk; Hampton Roads Center for Clinical Research
Research Study for Diabetics who suffer from Painful Diabetic Neuropathy

Virginia Beach; Advanced Pain Management & Rehabilitation Hilltop Medical Center
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Washington

Renton; Rainier Clinical Research Center, Inc.
Diabetic Neuropathy

Renton; Rainier Clinical Research Center Inc
A Randomized-Withdrawal Phase III Study Evaluating the Safety and Efficacy of CG5503 Extended-Release (ER) in Subjects with Painful Diabetic Peripheral Neuropathy (DPN)

Spokane; Rockwood Clinic P.S. Research Center
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Tacoma; Cedar Research
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.

Wisconsin

Madison; University of Wisconsin Hospital and Clinics
A clinical research study looking for patients who have been diagnosed with Type 1 or 2 Diabetes, experiencing painful neuropathy for 6 months to 10 years.